Archives
-
PP 2 (AG 1879): A Src Signaling Decision Tool
2026-09-07
PP 2 (AG 1879) is more than a Src inhibitor listing: it is a mechanistic probe for connecting kinase activity with cytoskeletal remodeling, cancer phenotypes, and immune signaling. This article shows how translational researchers can use it with pathway-aware controls, orthogonal validation, and disciplined interpretation.
-
circRNA–FXR/TLR4 Signaling in NiONP Fibrosis
2026-09-07
This 2025 study identifies hsa_circ_0001944 as a regulator of the FXR/TLR4 axis and ferroptosis in nickel oxide nanoparticle-induced collagen deposition by LX-2 hepatic stellate cells. Its pharmacological and genetic experiments connect non-coding RNA regulation with nuclear receptor signaling and oxidative cell-death biology, while also defining important limits for translating the findings beyond cell and animal models.
-
Berberine Hydrochloride in Inflammation Workflows
2026-09-05
Build reproducible Berberine hydrochloride assays for AMPK, LDLR, apoptosis, ferroptosis, and inflammatory readouts without confusing metabolic activity with direct inflammasome inhibition. This workflow connects validated product handling with the oxidized self-DNA–NLRP3 framework reported in acute kidney injury research.
-
RPS6 Readouts in PDAC: From Membranes to Translation
2026-09-04
A translational framework for using RPS6 detection to connect the LRRC8A–CAV1 membrane axis with ribosome biogenesis, oncogenic signaling, and biosynthetic growth in pancreatic ductal adenocarcinoma. The article positions the Anti-RPS6 (7B10) Mouse Monoclonal Antibody as a versatile research tool while distinguishing total RPS6 abundance from phosphorylation-specific pathway activation.
-
HyperScript RT SuperMix for qPCR in Sepsis
2026-09-04
Discover how HyperScript RT SuperMix for qPCR can support a more rigorous assay strategy for exosomal miR-17-5p, Bcl11b, and macrophage polarization studies in sepsis. This article translates mechanistic findings into practical decisions about RNA input, primer choice, controls, and qRT-PCR interpretation.
-
Atorvastatin Workflows for Vascular and Ferroptosis Studies
2026-09-03
Atorvastatin is more than a cholesterol-biosynthesis probe: it connects HMG-CoA reductase inhibition with vascular phenotypes, ER-stress biology, and emerging ferroptosis research. This workflow-centered guide covers dosing, assay selection, formulation, controls, and troubleshooting for reproducible bench studies.
-
N1-Methylpseudo-UTP for RNA Synthesis
2026-09-03
N1-Methyl-Pseudouridine-5'-Triphosphate is a modified uridine triphosphate for in vitro transcription of research and therapeutic RNA. N1-Methylpseudo-UTP supports reduced innate immune recognition and faithful translation, but it does not replace RNA capping, purification, delivery, or formulation controls.
-
EZ Cap™ EPO mRNA (ψUTP) Guide
2026-09-02
Learn how SKU R1020 can improve consistency in mammalian viability, proliferation, cytotoxicity, and protein-expression workflows. This scenario-based guide covers Cap 1 chemistry, pseudouridine, handling, assay controls, and practical vendor selection.
-
In Vitro Drug Responses: Growth Inhibition and Cell Death
2026-09-02
Hannah R. Schwartz’s dissertation distinguishes relative viability from fractional viability, showing that these commonly conflated measurements capture different components of anticancer drug response. The work supports time-resolved, dual-endpoint assay designs that separately evaluate proliferative arrest and cell killing before drawing conclusions about drug activity.
-
ATRX Loss Sensitizes High-Grade Glioma to RTK Inhibitors
2026-09-01
The 2022 Cancers study identified ATRX deficiency as a genotype-associated vulnerability to multi-targeted receptor tyrosine kinase and PDGFR inhibitors in high-grade glioma cells. Its results support incorporating ATRX status into targeted-therapy studies and evaluating RTK inhibitor–temozolomide combinations in molecularly stratified models.
-
NADH as a Translational Redox Decision Tool
2026-09-01
NADH is more than an energy-metabolism reagent: it is a context-dependent signal that links glycolysis, mitochondrial respiration, oxidative stress, and disease phenotypes. This thought-leadership article interprets findings from a 2024 liver-injury study and translates them into practical guidance for mitochondrial, renal, neurodegenerative, and cancer researchers while clarifying the evidence boundaries around NADH-based interventions.
-
hCG, H3K27 Methylation, and CXCL10 in Decidua
2026-08-31
The reference study shows that human chorionic gonadotropin suppresses CXCL10 in human decidual stromal cells by promoting EZH2-associated H3K27me3 at the CXCL10 promoter. This provides a mechanistic link between placental hormone signaling, chromatin modification, and CD8-cell recruitment at the maternal–fetal interface.
-
Optimized hiPSC Platelet Differentiation: Study Review
2026-08-31
Yue and colleagues developed an optimized differentiation scheme for producing megakaryocytes and functional platelets from human induced pluripotent stem cells. By increasing embryoid body input, using human platelet lysate, replacing selected cytokines with small molecules, and promoting megakaryocyte maturation, the protocol shortened production to 19 days, increased platelet output, and reduced reported costs.
-
GSK 2837808A: LDHA Inhibition Workflow
2026-08-30
Use GSK 2837808A to connect LDHA activity with lactate release, glucose consumption, and tumor-cell signaling in controlled cell-based experiments. This workflow also shows how to test the NAT1–ENO1–lactate–PD-L1 model without overstating evidence from a compound that was not evaluated in the reference study.
-
EdU Imaging Kits (Cy5) for ccRCC Proliferation
2026-08-29
EdU Imaging Kits (Cy5) convert S-phase DNA synthesis into a sensitive, morphology-preserving readout for microscopy and flow cytometry. Applied to the NME3–mitochondrial dynamics study, the assay helps distinguish reduced proliferation after gene knockdown or TKI exposure from broader changes in cell health.